TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Clinical trial NCT03306199 · COMPLETED

Trial details

NCT number: NCT03306199
Sponsor: Spectranetics Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Peripheral Arterial Disease

Start date: 2017-10-03
Primary completion: 2018-06-05
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.